Enantia has been fully acquired by Inveready, to drive an ambitious growth plan, including integrating specialized CROs. Enantia will expand into new markets while executing a targeted acquisition strategy to consolidate a group of highly specialized CROs serving the pharmaceutical, biotech, and materials industries.
| Cookie | Duration | Description |
|---|---|---|
| _ga | 1 year 1 month 4 days | Google Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors. |
| _ga_* | 1 year 1 month 4 days | Google Analytics sets this cookie to store and count page views. |
| _gat_gtag_UA_* | 1 minute | Google Analytics sets this cookie to store a unique user ID. |
| _gid | 1 day | Google Analytics sets this cookie to store information on how visitors use a website while also creating an analytics report of the website's performance. Some of the collected data includes the number of visitors, their source, and the pages they visit anonymously. |
| Cookie | Duration | Description |
|---|---|---|
| et_pb_ab_view_page_2250 | session | Description is currently not available. |
Contact
+34 934 034 837
